Anthony Desbien
About Anthony Desbien
Anthony Desbien is a Senior Scientist in Discovery Biology at RAPT Therapeutics with extensive experience in various therapeutics, including small molecules and biologics. He holds a Ph.D. in Immunology and Microbiology and has worked at several prominent research institutions, contributing to the clinical evaluation of immune-based therapies.
Work at Rapt Therapeutics
Anthony Desbien currently holds the position of Senior Scientist in Discovery Biology at RAPT Therapeutics. He has been with the company since 2021, contributing to the development of innovative therapies. His role involves leveraging his extensive background in immunology to support the discovery and evaluation of novel immune-based treatments.
Education and Expertise
Anthony Desbien earned a Doctor of Philosophy (Ph.D.) in Immunology and Microbiology from the University of Colorado at Denver, where he studied from 2003 to 2009. He also holds a Bachelor of Science (BS) in Microbiology from the University of Minnesota-Twin Cities, completed from 1996 to 2000. His educational background underpins his expertise in both innate and adaptive immunity, particularly regarding tumor and vaccination models.
Background
Anthony Desbien has a diverse professional background in the field of immunology and therapeutics. He began his career as a Research Associate at Fred Hutchinson Cancer Research Center from 2000 to 2003. He then worked as a Graduate Student in the Philippa Marrack Lab at National Jewish Health from 2003 to 2009. Following his graduate studies, he served as a Post Doctoral Scientist at the Infectious Disease Research Institute from 2009 to 2013.
Professional Experience at Aduro Biotech
At Aduro Biotech, Anthony Desbien held multiple roles, including Scientist II from 2015 to 2017, Senior Scientist from 2017 to 2019, and Associate Director of Translational Science and Immunology from 2019 to 2021. His work at Aduro focused on the development of immune-based therapies, enhancing his experience in translational science.
Achievements in Immunology
With over 11 years of experience, Anthony Desbien has specialized in leveraging basic immunology to support the clinical evaluation of novel immune-based therapies for various conditions, including cancer, autoimmunity, and infectious diseases. His work has contributed to advancements in understanding immune responses and therapeutic applications.